Beyond Air (XAIR) Income from Non-Controlling Interests (2021 - 2026)
Beyond Air (XAIR) posted Income from Non-Controlling Interests of -$86000.0 for Q1 2026, up 70.75% sequentially from -$294000.0 in Q4 2025, and down 196.55% YoY from $89071.4 in Q1 2025.
Beyond Air (XAIR) Income from Non-Controlling Interests (2021 - 2026) Analysis & Trends
Beyond Air has reported Income from Non-Controlling Interests for 6 years, with the latest figure at -$86000.0 in Q1 2026.
- Quarterly Income from Non-Controlling Interests fell 196.55% year-over-year to -$86000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.1 million (up 41.48% YoY) and the FY2026 annual result came in at -$1.1 million, up 41.48% from the prior year.
- Income from Non-Controlling Interests rose to -$86000.0 in Q1 2026 per XAIR's latest filing, from -$294000.0 in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at -$29000.0 in Q1 2025 and troughed at -$1.2 million in Q3 2023.
- A 5-year average of -$660882.4 and a median of -$720000.0 in 2022 frame the typical range for Income from Non-Controlling Interests.
- The sharpest annual moves came in 2022 and 2025: Income from Non-Controlling Interests tumbled 371.3% in 2022, then soared 96.58% in 2025.
- Over 5 years, Income from Non-Controlling Interests stood at -$1.1 million in 2022, then advanced by 1.24% to -$1.0 million in 2023, then jumped by 71.1% to -$300000.0 in 2024, then grew by 2.0% to -$294000.0 in 2025, then surged by 70.75% to -$86000.0 in 2026.
- According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered -$86000.0, -$294000.0, and -$318000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 900,000.00 |
| 10 | Beyond Air | 3.68 Mn | -7.23 Mn | 225,000.00 | -219,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -219,000.00 |
| Mar 31, 2026 | -86,000.00 |
| Dec 31, 2025 | -294,000.00 |
| Sep 30, 2025 | -318,000.00 |
| Jun 30, 2025 | -387,000.00 |
| Mar 31, 2025 | -29,000.00 |
| Dec 31, 2024 | -300,000.00 |
| Sep 30, 2024 | -671,000.00 |
| Jun 30, 2024 | -854,000.00 |
| Mar 31, 2024 | -849,000.00 |
| Dec 31, 2023 | -1.04 Mn |
| Sep 30, 2023 | -1.21 Mn |
| Jun 30, 2023 | -960,000.00 |
| Mar 31, 2023 | -984,000.00 |
| Dec 31, 2022 | -1.05 Mn |
| Sep 30, 2022 | -830,000.00 |
| Jun 30, 2022 | -720,000.00 |
| Mar 31, 2022 | -659,000.00 |
| Dec 31, 2021 | -223,000.00 |